Publication | Closed Access

Single nucleotide polymorphisms of cytarabine metabolic genes influence clinical outcome in acute myeloid leukemia patients receiving high-dose cytarabine therapy

Hematological MalignancyHealth SciencesHigh-dose Cytarabine TherapyGeneticsMedicineHematologyMyeloid NeoplasiaMixed-phenotype Acute LeukemiaPharmacogenomicsCytarabine Metabolic GenesPharmacologyRadiation OncologyCancer ResearchSingle Nucleotide Polymorphisms